Pharmacokinetic analysis of piperacillin administered with tazobactam in critically Ill, morbidly obese surgical patients.

被引：0
|
作者：
Sturm, Ashley W. [1 ]
Allen, Nichole [1 ]
Rafferty, Kelly D. [1 ]
Fish, Douglas N. [2 ]
Toschlog, Eric [1 ]
Newell, Mark [1 ]
Waibel, Brett [1 ]
机构：
[1] Vidant Med Ctr, Greenville, NC USA
[2] Univ Colorado, Aurora, CO USA
来源：
PHARMACOTHERAPY | 2013年 / 33卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
167E
引用
收藏
页码：E232 / E233
页数：2
相关论文
共 50 条
  • [21] Vancomycin/Piperacillin-tazobactam Nephrotoxicity in the Critically Ill
    Kollef, Marin H.
    Juang, Paul
    Micek, Scott T.
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (07) : 1520 - 1521
  • [22] Renal function in critically ill, morbidly obese patients
    Vincent, F
    El-Khoury, N
    Rondeau, E
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (12) : 1332 - 1333
  • [23] Dose optimization of piperacillin/tazobactam in critically ill children
    De Cock, Pieter A. J. G.
    van Dijkman, Sven C.
    de Jaeger, Annick
    Willems, Jef
    Carlier, Mieke
    Verstraete, Alain G.
    Delanghe, Joris R.
    Robays, Hugo
    Vande Walle, Johan
    Della Pasqua, Oscar E.
    De Paepe, Peter
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (07) : 2002 - 2011
  • [24] Outcomes of Extended-Infusion Piperacillin-Tazobactam: A Retrospective Analysis of Critically Ill Patients
    Lee, Grace C.
    Liou, Hansheng
    Yee, Russell
    Quan, Clifford F.
    Neldner, Katherine
    CLINICAL THERAPEUTICS, 2012, 34 (12) : 2297 - 2300
  • [25] Pharmacokinetics of piperacillin and tazobactam in critically Ill patients treated with continuous kidney replacement therapy: A mini-review and population pharmacokinetic analysis
    Selig, Daniel J.
    DeLuca, Jesse P.
    Chung, Kevin K.
    Pruskowski, Kaitlin A.
    Livezey, Jeffrey R.
    Nadeau, Robert J.
    Por, Elaine D.
    Akers, Kevin S.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (08) : 1091 - 1102
  • [26] Impact of renal replacement modalities on the clearance of piperacillin-tazobactam administered via continuous infusion in critically ill patients
    Roger, Claire
    Cotta, Menino O.
    Muller, Laurent
    Wallis, Steven C.
    Lipman, Jeffrey
    Lefrant, Jean-Yves
    Roberts, Jason A.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 (02) : 227 - 231
  • [27] Validation of an LC/UV Method for Piperacillin/Tazobactam Monitoring in Critically Ill Patients
    Zufia, L.
    Aquerreta, I
    Aldaz, A.
    THERAPEUTIC DRUG MONITORING, 2013, 35 (05) : 726 - 727
  • [28] Immunomonitoring in critically ill surgical patients.
    Faist, E
    Zedler, S
    Klein, M
    SHOCK, 2005, 23 : 1 - 1
  • [29] Renal function in critically ill, morbidly obese patients - Reply
    EL Solh, AA
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (12) : 1333 - 1333
  • [30] Population Pharmacokinetics of Piperacillin/Tazobactam in Critically Ill Young Children
    Cies, Jeffrey J.
    Shankar, Venkat
    Schlichting, Christine
    Kuti, Joseph L.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (02) : 168 - 173
12345